We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+6.82%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$373M
AUM Growth
+$136M
(+57%)
Cap. Flow
+$134M
Cap. Flow
% of AUM
35.95%
Top 10 Holdings %
Top 10 Hldgs %
8.63%
Holding
903
New
413
Increased
115
Reduced
67
Closed
307
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.88M |
| 2 |
Baidu
BIDU
|
+$2.88M |
| 3 |
VMW
VMware, Inc
VMW
|
+$2.6M |
| 4 |
Baxter International
BAX
|
+$2.58M |
| 5 |
Illumina
ILMN
|
+$2.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$2.56M |
| 2 |
Moderna
MRNA
|
+$2.27M |
| 3 |
Alibaba
BABA
|
+$1.88M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$1.87M |
| 5 |
Amazon
AMZN
|
+$1.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.26% |
| 2 | Healthcare | 13.7% |
| 3 | Industrials | 13.6% |
| 4 | Financials | 9.21% |
| 5 | Communication Services | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Vanguard Mid-Cap Growth ETF
VOT
$19.2B
| $271K | 0.07% |
+1,280
| New | +$278K |
|
452
Annaly Capital Management
NLY
$16.9B
| $270K | 0.07% |
7,745
-21,316
| -73% | -$722K |
|
453
Wabtec
WAB
$50.8B
| $269K | 0.07% |
3,370
-3,057
| -48% | -$237K |
|
454
Hilton Worldwide
HLT
$75.3B
| $268K | 0.07% |
+2,193
| New | +$253K |
|
455
Global X Lithium & Battery Tech ETF
LIT
$1.5B
| $267K | 0.07% |
+4,619
| New | +$302K |
|
456
Carnival Corporation Ltd
CCL
$37.1B
| $266K | 0.07% |
+9,979
| New | +$235K |
|
457
Denali Therapeutics
DNLI
$3.74B
| $265K | 0.07% |
+4,886
| New | +$327K |
|
458
Papa John's
PZZA
$997M
| $265K | 0.07% |
3,060
+687
| +29% | +$64.9K |
|
459
Companhia Siderúrgica Nacional
SID
$1.49B
| $265K | 0.07% |
+41,233
| New | +$260K |
|
460
Cogent Communications
CCOI
$612M
| $264K | 0.07% |
+3,919
| New | +$240K |
|
461
Viavi Solutions
VIAV
$9.41B
| $264K | 0.07% |
+16,971
| New | +$274K |
|
462
GoodRx Holdings
GDRX
$1.03B
| $263K | 0.07% |
+6,937
| New | +$312K |
|
463
Healthcare Realty
HR
$7.46B
| $263K | 0.07% |
+9,302
| New | +$260K |
|
464
Telus
TU
$16.2B
| $263K | 0.07% |
+10,409
| New | +$216K |
|
|
IRBT
465
DELISTED
iRobot
IRBT
| $262K | 0.07% |
+2,249
| New | +$256K |
|
466
Editas Medicine
EDIT
$411M
| $261K | 0.07% |
+6,456
| New | +$368K |
|
|
FSR
467
DELISTED
Fisker Inc.
FSR
| $261K | 0.07% |
+15,601
| New | +$285K |
|
468
Toll Brothers
TOL
$14.1B
| $257K | 0.07% |
+4,476
| New | +$234K |
|
469
Hartford Financial Services
HIG
$38.4B
| $255K | 0.07% |
+3,773
| New | +$204K |
|
470
RPM International
RPM
$13.8B
| $255K | 0.07% |
2,726
-1,052
| -28% | -$90.9K |
|
|
TIGR
471
UP Fintech Holding
TIGR
$877M
| $255K | 0.07% |
+17,355
| New | +$353K |
|
|
AMED
472
DELISTED
Amedisys
AMED
| $254K | 0.07% |
+976
| New | +$275K |
|
473
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.57B
| $253K | 0.07% |
+6,574
| New | +$274K |
|
|
HDV
474
iShares Core High Dividend ETF
HDV
$14.5B
| $253K | 0.07% |
+13,280
| New | +$242K |
|
475
Kinsale Capital Group
KNSL
$8.24B
| $253K | 0.07% |
1,557
+180
| +13% | +$33K |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q1 2021 Portfolio in Review
As of Q1 2021, Y-Intercept (HK) held 903 positions worth $373M, up 57% from $237M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Y-Intercept (HK) deployed $134M of net new capital in Q1 2021, opening 413 new positions and adding to 115 existing holdings. Its largest new stake was VMware, Inc: 18,176 shares worth $2.73M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Moderna, an estimated $2.27M trimmed.
- Y-Intercept (HK)'s largest Q1 2021 buy was VMware, Inc: 18,176 shares worth $2.73M.
- Y-Intercept (HK) added most to Apple in Q1 2021, an estimated $4.88M increase.
- Y-Intercept (HK)'s biggest Q1 2021 reduction was Moderna, cutting an estimated $2.27M.
- Y-Intercept (HK) fully exited DuPont de Nemours in Q1 2021, selling an estimated $2.56M.
- Y-Intercept (HK)'s ten largest holdings make up 8.6% of its $373M portfolio in Q1 2021.
- Y-Intercept (HK) opened 413 new positions and closed 307 in Q1 2021.
- Y-Intercept (HK)'s portfolio value rose 57% quarter-over-quarter to $373M.
Based on Y-Intercept (HK)'s 13F filing for Q1 2021, filed 12 May 2021.